MELANIE BURNETT: Open Payments
NPI 1275992968 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$446 in 25 payments from 15 companies in 2025. Trend: 2023 $906 · 2024 $659 · 2025 $446
Food & beverage: $446
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $106 |
| ABIOMED | 3 | $51 |
| Amgen Inc. | 3 | $47 |
| Eisai Inc. | 2 | $37 |
| PFIZER INC. | 2 | $33 |
| Dexcom, Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: LEQVIO, Leqembi, ELIQUIS, OTEZLA, Dexcom G6 Transmitter, GEMTESA, JARDIANCE, SPRAVATO.
Industry payments across SC — which companies pay providers there.
